TRANSFUSION HEALTH LLC has a total of 18 patent applications. It increased the IP activity by 900.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SAE HAN PHARM CO LTD, MEDICAMENTE INTREPRINDEREA DE and DEQING WEIKANG BIOTECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | United States | 2 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Medical technology | |
#6 | Control |
# | Name | Total Patents |
---|---|---|
#1 | Webb Timothy | 15 |
#2 | Cotari Jesse | 13 |
#3 | Wang Zhan | 10 |
#4 | Jacobson Stuart Alexander | 4 |
#5 | Rebo Justin | 4 |
#6 | Loving Kathryn | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020223517A1 | Methods of making oligopotent and unipotent precursors | |
WO2020223383A1 | Compositions and methods of making expanded hematopoietic stem cells using derivatives of carbazole | |
KR20200094141A | Composition and method for producing augmented hematopoietic stem cells using a derivative of fluorene | |
WO2018217567A1 | Compositions and methods of making expanded hematopoietic stem cells using pten inhibitors | |
WO2017193009A1 | Maintenance, enrichment, enhancement and expansion of human hematopoietic stem cells |